These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 38320225)
41. Reply to Soman et al, Alffenaar et al, Metcalfe et al, and Raoult. Cegielski JP; Chen MP; Tupasi TE; Leimane V; Volchenkov GV; Clin Infect Dis; 2015 Mar; 60(6):971-3. PubMed ID: 25527654 [No Abstract] [Full Text] [Related]
42. Reply to R.D. Nipp et al, M.-J. Molina-Garrido et al, and A. Gajra et al. Corre R; Léna H; Vergnenègre A; Chouaïd C J Clin Oncol; 2016 Nov; 34(33):4050-4051. PubMed ID: 27551125 [No Abstract] [Full Text] [Related]
43. Reply to M.S. Copur et al, A. Taylor et al, and P.S. Rajagopal et al. Beitsch P; Hughes K; Whitworth P J Clin Oncol; 2019 Aug; 37(24):2178-2180. PubMed ID: 31246521 [No Abstract] [Full Text] [Related]
44. N400, the reference electrode, and the semantic activation in prime-task experiments: a reply to Dombrowski and Heil (2006). Marí-Beffa P; Catena A; Valdés B; Cullen D; Houghton G Brain Res; 2007 May; 1147():209-12. PubMed ID: 17328874 [TBL] [Abstract][Full Text] [Related]
45. Is the Personal Identity Debate a "Threat" to Neurosurgical Patients? A Reply to Müller et al. Nyholm S Neuroethics; 2018; 11(2):229-235. PubMed ID: 29937948 [TBL] [Abstract][Full Text] [Related]
46. Reply to S.G. Chun et al, A. Levy et al, and N. Andratschke et al. Gondi V; Brown PD J Clin Oncol; 2020 Oct; 38(29):3455-3457. PubMed ID: 32783673 [No Abstract] [Full Text] [Related]
47. Reply to C.L. Braal et al, H. Brauch et al, and M.P. Goetz et al. Guchelaar HJ; Sanchez-Spitman A; Dezentjé V; Böhringer S; Swen J; Neven P; Gelderblom H J Clin Oncol; 2019 Aug; 37(22):1984-1985. PubMed ID: 31211601 [No Abstract] [Full Text] [Related]
49. Reply to A. Messori et al, R. Bordonaro et al, and G. Fasola et al. Goldstein DA; El-Rayes BF; Chen Q; Flowers CR J Clin Oncol; 2015 Nov; 33(32):3842-3. PubMed ID: 26304876 [No Abstract] [Full Text] [Related]
50. Reply to A. Messori et al, R. Bordonaro et al, and G. Fasola et al. Saltz LB J Clin Oncol; 2015 Nov; 33(32):3843-4. PubMed ID: 26304894 [No Abstract] [Full Text] [Related]
51. Reply to H.J.A. Adams et al, E.A. Hawkes et al, and C.F. Hess et al. Borchmann P; Engert A J Clin Oncol; 2017 Jan; 35(3):375-376. PubMed ID: 28095272 [No Abstract] [Full Text] [Related]
52. Reply to C. Le Péchoux et al and B.S. Gill et al. Robinson CG; Patel AP; DeWees T; Morgensztern D; Bradley JD; Puri V J Clin Oncol; 2015 Sep; 33(26):2932-3. PubMed ID: 26215956 [No Abstract] [Full Text] [Related]
53. Reply to Park et al, Muldoon et al, and Périllaud-Dubois et al. Leruez-Ville M; Faure-Bardon V; Magny JF; Parodi M; Ville Y Clin Infect Dis; 2020 Jan; 70(1):176-177. PubMed ID: 31090895 [No Abstract] [Full Text] [Related]
54. Reply to the Letter of Terracini B. et al. "Comment on Piscitelli et al. Hospitalizations in Pediatric and Adult Patients for All Cancer Type in Italy: The EPIKIT Study under the E.U. COHEIRS Project on Environment and Health". Int. J. Environ. Res. Public Health 2017, 14, 495. Piscitelli P; Marino I; Falco A; Rivezzi M; Neglia C; Della Rosa G; Militerno G; Bonifacino A; Rivezzi G; Romizi R; Miserotti G; Montella M; Bianchi F; Marinelli A; De Donno A; De Filippis G; Serravezza G; Di Tanna G; Gennaro V; Ascolese M; Distante A; Burgio E; Colao A Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29068388 [TBL] [Abstract][Full Text] [Related]
55. Comments to the Letter to the Editor of S. Shahsavari et al. concerning "Predicting medical complications in spine surgery: evaluation of a novel online risk calculator" by M. F. Kasparek et al. (Eur Spine J: doi:10.1007/s00586-018-5707-9) and the reply to the Letter to the Editor of S. Shahsavari et al. concerning "Predicting medical complications in spine surgery: evaluation of a novel online risk calculator" by M. F. Kasparek et al. (Eur Spine J: doi:10.1007/s00586-018-5707-9). Edwards KL Eur Spine J; 2018 Nov; 27(11):2889-2890. PubMed ID: 30327911 [No Abstract] [Full Text] [Related]
56. Reply to S.C. Adams et al, C. Lopez et al, and R.U. Newton et al. Hardcastle SJ; Cohen PA J Clin Oncol; 2018 Mar; 36(9):928-930. PubMed ID: 29373095 [No Abstract] [Full Text] [Related]
57. Reply to Kersting et al. Comment on "Wunsch et al. The Impact of COVID-19 on the Interrelation of Physical Activity, Screen Time and Health-Related Quality of Life in Children and Adolescents in Germany: Results of the Motorik-Modul Study. Wunsch K; Nigg C; Niessner C; Schmidt SCE; Oriwol D; Hanssen-Doose A; Burchartz A; Eichsteller A; Kolb S; Worth A; Woll A Children (Basel); 2021 Jun; 8(7):. PubMed ID: 34201594 [TBL] [Abstract][Full Text] [Related]
58. Letter by Mutlu and Budinger Regarding Article, "Particulate Matter Exposure and Stress Hormone Levels: A Randomized, Double-Blind, Crossover Trial of Air Purification". Mutlu GM; Budinger GRS Circulation; 2018 Mar; 137(11):1203-1204. PubMed ID: 29530899 [No Abstract] [Full Text] [Related]
59. Reply to the letter to the editor 'Reply to Solinas et al, venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review' by Frere et al. Petrelli F; Solinas C Thromb Res; 2021 Dec; 208():217-218. PubMed ID: 33810866 [No Abstract] [Full Text] [Related]